Mode
Text Size
Log in / Sign up

External health financing volatility correlates with reduced pandemic preparedness across Central Asian health systemsFinancing Volatility Impacts Pandemic Preparedness in Central Asian Health Systems

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that external financing volatility is linked to inconsistent pandemic preparedness levels in Central Asian health systems.

This policy and practice review analyzes the impact of external health financing volatility on pandemic preparedness within health systems in Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. The scope includes evaluating ODA from various sources including OECD, Chinese Belt and Road Initiative, and Eurasian Economic Union to determine their influence on infrastructure stability.

The analysis identifies significant fluctuations in regional ODA volume, which increased from USD 160.2 million in 2019 to USD 307.1 million in 2021, before decreasing to USD 227.5 million in 2023. Concurrently, the review notes a decline in Kazakhstan's SPAR score from 88 to 67 between 2021 and 2023. In Tajikistan, health expenditure as a percentage of GDP was reported between 7.0% and 8.9%.

A primary limitation is that this is not a primary trial; it relies on secondary datasets from the OECD and WHO. The findings suggest an association between aid contraction and declining preparedness in Kazakhstan, while a correlation exists between high spending and lower scores in Tajikistan. These results highlight how financing volatility may drive health system instability, suggesting a need for multi-year pooled funding and domestic budget ring-fencing to stabilize regional health infrastructure.

This policy review examined the relationship between external health financing and pandemic preparedness across five countries in Central Asia: Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. The study looked at data from international organizations to see how changes in aid funding affected local health systems.

The findings showed significant fluctuations in regional aid volumes over a few years. For example, while some funding increased between 2019 and 2021, it decreased significantly between 2021 and 2023. In Kazakhstan, these changes were linked to a drop in health preparedness scores from 88 down to 67.

Because this is a policy review based on secondary data rather than a clinical trial, the results show links rather than direct causes. The report suggests that inconsistent funding makes it harder for local systems to stay stable. Experts recommend moving toward multi-year funding and protected domestic budgets to create more reliable health systems.

What this means for you:
Unstable international funding may link to lower pandemic preparedness scores in Central Asian health systems.

Common questions

How did funding change in the region?

Regional aid volume increased from USD 160.2 million in 2019 to USD 307.1 million in 2021, but then decreased to USD 227.5 million by 2023.

What happened to preparedness scores in Kazakhstan?

The study noted a decline in the Kazakhstan SPAR score from 88 in 2021 to 67 in 2023, which was a reduction of 21 points.

What are the recommendations for health systems?

The review suggests moving toward multi-year pooled funding and ring-fencing domestic budgets to help stabilize health systems against financing volatility.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
The COVID-19 pandemic exposed the structural fragility of health systems built on volatile external financing. Central Asia—Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan—receives health financing from three divergent donor streams: OECD bilateral and multilateral channels, Chinese Belt and Road Initiative mechanisms, and Eurasian Economic Union frameworks. The 2025 suspension of USAID operations, which eliminated 69–78% of program funding in Kyrgyzstan and Tajikistan, transformed chronic financing instability into an acute system-level shock. The relationship between external health financing volatility and pandemic preparedness in Central Asia has not previously been systematically analyzed. This policy and practice review draws on three publicly available datasets: OECD Creditor Reporting System health-sector official development assistance (ODA) (sector 120, all donors, constant 2022 USD, 2010–2023); WHO IHR State Party Self-Assessment Annual Reporting composite scores (2018–2023); and WHO Global Health Expenditure Database Figures (2018–2023). Aid volatility was operationalized as the coefficient of variation of annual health-sector disbursements. Health sector (ODA) is structurally volatile across all five countries, with coefficient of variation values ranging from 21.3% (Kyrgyzstan) to 53.5% (Uzbekistan). The regional aggregate surged from a pre-COVID-19 mean of USD 160.2 million to USD 307.1 million in 2021, then contracted to USD 227.5 million by 2023. A systematic disconnect between financing volume and preparedness outcomes is evident: Kazakhstan sustained the region’s highest World Health Organization State Party Self-Assessment Annual Reporting (WHO SPAR) scores despite the lowest health aid in absolute terms, while Tajikistan’s current health expenditure of 7.0–8.9% of GDP did not prevent SPAR scores from remaining below the 2024 global average of 64. Kazakhstan’s SPAR score fell from 88 in 2021 to 67 in 2023, coinciding with post-COVID-19 aid contraction—a pattern consistent with financing instability rather than capacity management failure. Aid volatility, not volume alone, undermines pandemic preparedness in Central Asia. Five policy recommendations are advanced: multi-year pooled financing windows under the World Bank Pandemic Fund; redirecting Chinese Belt and Road Initiative health financing through multilateral channels; expanding the Eurasian Economic Union health security mandate with a dedicated preparedness mechanism; increasing domestic health budgets with ring-fenced IHR capacity lines; and integrating an Aid Volatility Index into the WHO IHR Monitoring and Evaluation Framework. Financing predictability is the primary structural imperative for sustaining preparedness in the post-pandemic era.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.